This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q55014544
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2009 article artículu científicu наукова стаття, опублікована у вересні 2009 wetenschappelijk artikel ലേഖനം
p:P577
wds:Q55014544-CD8671A3-4054-4E75-9949-CED215605E54
wdt:P577
2009-09-01T00:00:00Z
p:P2093
wds:Q55014544-60D3654D-6E41-431E-8508-AF56F7BA08CF wds:Q55014544-34637AA1-90FE-4729-A8F7-38B5D51568AF
wdt:P2093
Robert C. Brunner Jay M. Meythaler
rdfs:label
A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke
skos:prefLabel
A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke
schema:name
A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke
p:P50
wds:Q55014544-8055D5D9-285F-4BA9-9A1F-2667B985FB79
wdt:P50
wd:Q51990823
p:P1476
wds:Q55014544-0E48178C-ABBC-403B-BB78-412B05984813
wdt:P1476
A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke
p:P304
wds:Q55014544-62AE6557-8320-4058-8B5D-18D4C2D7864A
wdt:P304
1453-1461
p:P31
wds:Q55014544-B87E554F-36F9-481D-8655-BBA55ED87231
wdt:P31
wd:Q13442814
p:P698
wds:Q55014544-D5A1622F-CAC3-47E8-A3B9-83BCD72CDC1B
wdtn:P698
n9:19735771
wdt:P698
19735771
p:P1433
wds:Q55014544-6313F260-82EA-4E8F-9B35-FB482EF6E442
wdt:P1433
wd:Q4787307
p:P433
wds:Q55014544-40331710-DFBA-4E1F-93AA-20231F758C60
p:P478
wds:Q55014544-33A13B0F-9BC6-469B-BD17-135A66D6D3E2
wdt:P433
9
wdt:P478
90
p:P356
wds:Q55014544-B1C1D12F-AC39-45C8-834A-EADEEA89C510
wdtn:P356
n12:J.APMR.2009.02.026
wdt:P356
10.1016/J.APMR.2009.02.026